(Q45944471)

18 December 2017

title

Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study. (English)

1 reference

18 December 2017

0 references

1 reference

1 reference

2

Henrik Toft Sørensen

0 references

Timothy L Lash

5

object named as

Timothy L Lash

1 reference

18 December 2017

author name string

Rohini K Hernandez

1

1 reference

18 December 2017

Lars Pedersen

3

1 reference

18 December 2017

Jacob Jacobsen

4

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

18 December 2017

published in

Cancer

1 reference

18 December 2017

volume

115

1 reference

18 December 2017

issue

19

1 reference

18 December 2017

page(s)

4442-4449

1 reference

18 December 2017

Epidemiology of thrombosis in cancer

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Venous thromboembolism and cancer: risks and outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Epidemiology. When an entire country is a cohort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Cancer and venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.24508

1 reference

7 January 2021

Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24508

7 January 2021

Identifiers

DOI

10.1002/CNCR.24508

1 reference

18 December 2017

1 reference

18 December 2017